Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 306

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD

Open access
Srivastava, Anand, Kaze, Arnaud D., McMullan, Ciaran J., Isakova, Tamara, Waikar, Sushrut S.·2018·American Journal of Kidney Diseases

Abstract

Background Plasma uric acid levels rise in chronic kidney disease (CKD) and may lead to tubular injury, endothelial dysfunction, oxidative stress, and intra-renal inflammation. Whether uric acid levels are associated with kidney failure and death in CKD is unknown. Study Design A prospective, observational, cohort study. Settings & Participants 3885 individuals with CKD stages 2–4 enrolled in the Chronic Renal Insufficiency Cohort (CRIC) between June 2003 and September 2008, and followed up through March 2013. Predictor Baseline serum uric acid levels. Outcomes Kidney failure (initiation of dialysis or transplantation) and all-cause mortality. Results During a median follow-up of 7.9 years, 885 participants progressed to kidney failure, and 789 participants died. After adjustment for demographic, cardiovascular, and kidney-specific covariates, higher levels of uric acid were independently associated with risk of kidney failure in participants with an estimated glomerular filtration rate ≥ 45 mL/min/1.73 m2 (adjusted HR per 1–standard deviation [SD] greater baseline uric acid, 1.40; 95% CI, 1.12–1.75), but not in those with eGFR < 30 mL/min/1.73 m2. There was a nominally higher HR in participants with an eGFR of 30–44 (adjusted HR, 1.13; 95% CI, 0.99–1.29), but this did not reach statistical significance. The relationship between uric acid and all-cause mortality was J-shaped (P = 0.007). Limitations Potential residual confounding through unavailable confounders; lack of follow-up measurements to adjust for changes in uric acid levels over time. Conclusions Uric acid is an independent risk factor for kidney failure in earlier stages of CKD, and has a ‘J-shaped’ relationship with all-cause mortality in CKD. Adequately powered randomized, placebo-controlled trials in CKD are needed to test whether urate lowering may prove to be an effective approach to prevent complications and progression of CKD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.ajkd.2017.08.017

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Metadata

Authors
Srivastava, A., Kaze, A. D., McMullan, C. J., Isakova, T., & Waikar, S. S.
Venue
American Journal of Kidney Diseases
Publisher
Elsevier BV
Published
2018-03
Volume
71
Issue
3
Pages
362-370
ISSN
0272-6386 (ISSN-L)
OpenAlex
W2767610685
Cited by
306
References
48
FWCI
12.67
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD. https://app.cochat.ai/papers/10.1053/j.ajkd.2017.08.017
The paper
Srivastava, A., Kaze, A. D., McMullan, C. J., Isakova, T., & Waikar, S. S. (2018). Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2017.08.017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.